Completed NA INTERVENTIONAL NCT00002039
An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients
Sponsor: Astra USA
Conditions
Cytomegalovirus Retinitis HIV Infections
Interventions
Foscarnet sodium
Updated 5 times since 2017 Last updated: Jun 23, 2005
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT00002039, this NA trial focuses on Cytomegalovirus Retinitis and HIV Infections and remains completed. Sponsored by Astra USA, it has been updated 5 times since 2026, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Astra USA
Data source: NIH AIDS Clinical Trials Information Service
For direct contact, visit the study record on ClinicalTrials.gov .